PPP3R1 and Alzheimer disease: Bioinformatics analysis indicated that the downregulation of PPP3R1 can serve as novel biomarkers for patients with AD and the potential mechanisms of low PPP3R1 involved in AD pathogenesis mainly involve in axon guidance, glutamatergic-mediated synapses transport, LTP, and MAPK signaling pathway (62).